XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net cash flows from operating activities:      
Net loss $ (13,359) $ (30,690) $ (19,192)
Adjustments to reconcile net loss to net cash from operating activities:      
Depreciation and amortization 24,205 23,076 22,442
Non-cash compensation 14,242 14,422 12,344
Non-cash lease expense 4,915 4,541 4,666
Write-down of inventories and deferred preservation costs 4,434 4,785 4,374
Non-cash interest expense 3,866 1,858 1,832
Deferred income taxes (1,511) (1,385) (1,717)
Change in fair value of contingent consideration (11,010) 23,490 (9,000)
Endospan fair value adjustments 4,329 5,000 0
Loss on extinguishment of debt 3,669 0 0
Gain from sale of non-financial assets 0 (14,250) 0
Other 5,699 1,358 2,268
Changes in operating assets and liabilities:      
Receivables (15,395) (4,050) (13,340)
Inventories and deferred preservation costs (6,137) (14,360) (8,404)
Prepaid expenses and other assets (5,209) 535 (2,234)
Accounts payable, accrued expenses, and other liabilities 9,498 4,495 808
Net cash flows provided by (used in) operating activities 22,236 18,825 (5,153)
Net cash flows from investing activities:      
Capital expenditures (11,188) (9,752) (10,715)
Payments under Endospan agreements (17,000) (5,000) 0
Proceeds from sale of non-financial assets, net 0 14,250 0
Net cash flows used in investing activities (28,188) (502) (10,715)
Net cash flows from financing activities:      
Proceeds from issuance of long-term debt 184,000 0 0
Proceeds from revolving credit facility 28,500 0 0
Repayment of debt (211,831) (2,772) (2,753)
Proceeds from exercise of stock options and issuance of common stock 5,728 3,955 3,368
Payment of debt issuance costs (2,544) (249) 0
Proceeds from financing insurance premiums 0 3,558 0
Principal payments on short-term notes payable (1,027) (2,531) 0
Redemption and repurchase of stock to cover tax withholdings 0 (559) (1,795)
Other (623) (537) (459)
Net cash flows provided by (used in) financing activities 2,203 865 (1,639)
Effect of exchange rate changes on cash and cash equivalents (1,728) 401 1,848
(Decrease) increase in cash and cash equivalents (5,477) 19,589 (15,659)
Cash and cash equivalents, beginning of year 58,940 39,351 55,010
Cash and cash equivalents, end of year $ 53,463 $ 58,940 $ 39,351